Sustained release formulations comprising lamotrigine

Details for Australian Patent Application No. 2007202294 (hide)

Owner Glaxo Group Limited

Inventors Karolak, Wlodzimierz; Goodson, Gary Wayne; Currie, Robin; Parr, Alan Frank; Vijay-Kumar, Akunuri Venkata; Buxton, Ian Richard; Muppirala, Gopal; Sidhu, Jagdev Singh; Iyer, Vijay Mohan; Maleki, Mehran; Dela-Cruz, Myrna A; Stagner, Robert Allen

Agent Davies Collison Cave

Pub. Number AU-A-2007202294

Parent 2003260336

Filing date 22 May 2007

Wipo publication date 14 June 2007

International Classifications

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/30 (2006.01) Medicinal preparations characterised by special physical form - Organic coatings

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/08 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

7 June 2007 Complete Application Filed

14 June 2007 Application Open to Public Inspection

  Published as AU-A-2007202294

12 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202295-Method and apparatus for network management using perceived signal to noise and interference indicator

2007202293-Process for use with dual-fuel systems